Loading clinical trials...

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00004938

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

OBJECTIVE: I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.

Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID)•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.

NCT06523998 · Sporotrichosis, Chromomycosis, and more

COMPLETEDPhase 2

Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

NCT00004808 · Histoplasmosis, Sporotrichosis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2006Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment30

Start dateAug 1996

Last updatedJun 9, 2006

Condition

Sporotrichosis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2006Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions